| Project/Area Number |
10044253
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B).
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Virology
|
|---|
| Research Institution | TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY |
|---|
Principal Investigator |
KAGEYAMA Seiji Faculty of Medicine, TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY Associate Professor, 医学部, 助教授 (60252706)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SHIRAKI Kimiyasu Faculty of Medicine, TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY Professor, 医学部, 教授 (50135745)
SAPLE DG グランド医科大学, 助教授
MANIAR JK グランド医科大学, 教授
|
|---|
| Project Period (FY) |
1998 – 1999
|
| Project Status |
Completed (Fiscal Year 1999)
|
| Budget Amount *help |
¥2,400,000 (Direct Cost: ¥2,400,000)
Fiscal Year 1999: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1998: ¥1,300,000 (Direct Cost: ¥1,300,000)
|
|---|
| Keywords | HIV-2 / HIV-1 / AIDS / Seronegative / replication / V3-loop |
|---|
| Research Abstract |
Seronegative HIV-2 carriers have been found in India. Proviral HIV-2 was detected from 11 seronegative individuals for. HIV-1 and 2. Two HIV-2 strains were detected from the culture of peripheral blood mononuclear cells of two individuals among those. Those isolates belonged to subtype A. After the successful infection to immortalized T cells HIV-2 antigen in the cells was detected by anti-HIV-2 antibody. However, the antibody in the individual from whom HIV-2 was isolated could not be bound to the HIV-2 antigen. Those results imply the presence of HIV-2 in India.
The immune response to HIV-2 may act effectively. This may attributed to the fact that HIV-2 does not proliferate as much as HIV-1. Therefore immune evasion does not occur so often. As a result the amount of antigen was not enough to generate seroconversion in some cases. This was corroborated by the no alteration of amino acid sequence in V3-loop of HIV-2 during three years observation. Further careful observation is still on going to clarify the window period of HIV-2 infection as. The case of immune evasion is also focusing on as the future study.
|
